Neurothekeoma is an uncommon, benign neoplasm presenting in young adults, primarily on the head and neck. It was initially related to nerve sheath myxoma but with the advent of immunohistochemistry, new insights into its cellular differentiation and origin have emerged, unlinking Neurothekeoma and nerve sheath myxoma. Herein we describe a 19-year-old male who had had a frontal, fl esh-colored, asymptomatic papule for 2 years. Histology showed a dermal fusocellular-spindle cell tumor, including an eosinophilic cytoplasm with mild cellular pleomorphism and moderately dense fi brous stroma. IHQ was positive for CD10 and negative for S100 and Claudin-1. These fi ndings were compatible with cellular Neurothekeoma. The lesion was completely extirpated and at the 6-month follow-up, the patient was asymptomatic and had experienced no recurrences.
INTRODUCTION
Neurothekeoma (NT) is an uncommon, benign, dermal tumor. It was described by Harkin and Reed 1 in 1969 as a cutaneous tumor of neural origin named "nerve sheath myxoma". NT manifests as pink-erythematous, dome-shaped, solitary papules, generally of under 1 cm in diameter; with slow growth, fi rm consistency and usually asymptomatic. It is mainly located on the face, neck, arms and shoulders of young adults, and is more frequent in females. [1] [2] [3] [4] Nerve sheath myxoma (NSM) has often been regarded as falling within the spectrum of NT, though this is currently a source of discussion among most authors, in light of the advent of immunohistochemistry (IHQ).
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CASE REPORT
A 19 year-old, otherwise healthy male presented with a 2-year history of an asymptomatic frontal lesion. A fi rm, erythematous, non-tender, frontal papule was found ( Figure 1 ). Defi nitive diagnosis was uncertain with physical examination and the differential diagnosis included a dermal nevus, a Spitz nevus, an adnexal tumor and a spontaneous keloid. Complete excision and microscopic examination was performed, showing a non-capsulated, dermal, fusocellular-spindle cell tumor with eosinophilic cytoplasm, including mild, cellular pleomorphism and moderately dense fi brous stroma without myxoid matrix (Figure 2 ). No atypical cells or mitotic fi gures were seen. IHQ was positive for CD10 and negative for S100 and Claudin-1 ( Figure 3 ). This was compatible with cellular NT. At the 6-month follow-up, the patient was asymptomatic without recurrence signs and excellent healing process.
DISCUSSION
NT is an infrequent, dermal tumor with a twofold female predominance.
1,2,6-8 It is more common in the second decade of life. The mean age at diagnosis is 17 years: 25% occur in patients aged under 10, 59% in individuals under 20, and 80% in patients under 30. 2, 3, 9 However, diagnosis should also be suspected in older patients.
1,2 Local trauma and estrogen use have been identifi ed as triggering factors, which may explain the 2:1 ratio in females. 9, 10 Clinically, it manifests as an asymptomatic, pink-erythematous, dome-shaped, solitary papule, with a slow growth rate (mean time 7 months).
2 Differential diagnosis is broad, including benign and ma- It is commonly located (70%) on the head (34%), arms (20%) and shoulders (15%). On the head, it affects the nose (27%) and scalp (24%) mainly. 2 The presence of spindle and epithelioid cells with abundant granular-eosinophilic cytoplasm and a tendency to be grouped in whorled nodules spared by collagen bundles in the dermis and subcutaneous area, constitute the presumptive diagnosis. There may be sclerotic collagen and osteoclastlike cells. 2 Depending on the amount of myxoid matrix, NT can be classifi ed into cellular NT (< 10% myxoid matrix), mixed NT (10 -50% myxoid matrix) and myxoid NT (> 50% myxoid matrix). IHQ of NT almost always shows a reaction to NK1/C3 and CD10. S-100, HMB-45, Melan-A and CD56 are usually negative (Figure 4) . 2, 3 The cell of origin for NT is still unknown. NSM has been linked to myxoid NT repeatedly. It has been argued that NT has nerve sheath differentiation and is part of NSM. Although this remains controversial due to the lack of positive reaction to S-100 in all NT variants, we agree with Fetsch et al. and consider a neural differentiation very improbable (Figure 4) . We also recognize the possibility of fi bro-hystiocitic lineage. 2 Few studies have evaluated the prognosis of NT. After adjusting confounding variables, the real re-CHART 1: Differential (clinical and histological) diagnosis of Neurothekeoma. We placed the conditions in descending order of frequency 2 Risk factors for recurrence are: myxoid type, being female, facial location, younger age at diagnosis, positive margins, and absence of fat-tissue in the sample. 2 The presence of cellular atypia and the number of mitoses were not associated with an increased recurrence rate.
2 For these reasons, we perform 1 -2 mm margins elliptic deep excisions for NT.
An atypical variant of NT (ANT) has recently been described. Some authors defi ne ANT as entailing larger tumors (up to 6cm) of deep penetration (skeletal muscle and subcutaneous fat involvement), diffuse infi ltrative borders, vascular invasion, a high mitotic index (>3 mitosis per 10 high power fi elds) and pleomorphism. 7 This variant has been incompletely characterized and its clinical behavior is not entirely understood because of the scarcity of reports. 1, 6, 7 In a series involving 10 ANT patients, no local recurrence or metastasis was found in 1 to 5 years of follow-up. It seems that this "histologic aggressiveness" is not correlated with a "clinical aggressiveness". 6 Still, it is preferable to perform a complete excision of ANT with free margins, until they are more accurately characterized.
Our case confi rms the non-specifi c, clinical appearance of NT and underlines the importance of the biopsy for defi nitive diagnosis of NT. We do agree with the authors who favor a likely fi bro-hystiocitic differentiation for this lesion.❑
